Journal of Healthcare Engineering / 2022 / Article / Tab 1 / Research Article
Study on the Clinical Implications of NLR and PLR for Diagnosing Frailty in Maintenance Hemodialysis Patients and Their Correlations with Patient Prognosis Table 1 Comparison of related influencing factors of frailty in patients with 1MHD.
Categories Frailty group (n = 72) Nonfrailty group (n = 113) χ 2 /t /Z valueMale (n (%)) 31 (43.06) 57 (50.44) 0.962 0.327 Age (years) 59.4 ± 13.7 53.2 ± 13.9 3.261 0.001 Dialysis duration (months) 66.94 (35.12, 88.72) 67.22 (34.21, 86.23) 0.573 0.632 Education years 8.65 ± 2.67 8.94 ± 2.86 0.582 0.552 Dialysis adequacy 1.43 ± 0.26 1.66 ± 0.27 5.726 <0.001 Type 2 diabetes mellitus (n (%)) 28 (38.89) 31 (27.43) 2.657 0.103 Coronary artery disease (n (%)) 14 (19.44) 19 (16.81) 0.208 0.649 SA (g/L) 37.16 ± 4.01 40.41 ± 3.25 6.058 <0.001 Hemoglobin (g/L) 107.62 ± 19.81 112.14 ± 15.47 1.734 0.085 Predialysis blood urea nitrogen (mmol/L) 25.74 ± 7.25 26.78 ± 7.36 0.943 0.347 Predialysis serum creatinine (umol/L) 583.82 (252.34, 762.12) 629.72 (272.67, 782.45) 1.432 0.156 Uric acid (umol/L) 463.24 ± 74.59 446.87 ± 71.26 1.496 0.136 Triglyceride (mmol/L) 1.71 (1.17, 2.34) 1.84 (1.12, 2.19) 0.675 0.485 Total cholesterol (mmol/L) 3.84 ± 0.79 3.92 ± 0.73 0.451 0.704 High-density lipoprotein (mmol/L) 1.01 ± 0.33 1.09 ± 0.36 1.522 0.130 Low-density lipoprotein (mmol/L) 3.38 ± 0.74 3.42 ± 0.71 0.368 0.714 Blood potassium (mmol/L) 4.74 ± 0.78 4.52 ± 0.74 1.930 0.055 Blood calcium (mmol/L) 2.04 ± 0.21 2.07 ± 0.23 0.894 0.372 Blood phosphorus (mmol/L) 1.92 ± 0.48 1.85 ± 0.49 0.955 0.341 NLR 4.18 ± 1.02 2.55 ± 0.95 11.091 <0.001 PLR 129.96 ± 12.62 112.62 ± 13.36 8.787 <0.001 Body mass index (kg/m2 ) 20.26 ± 2.58 21.01 ± 2.76 1.823 0.07 GS (kg) 20.11(14.32, 21.21) 28.72 (19.21, 36.72) 4.785 <0.001 WS (m/s) 0.65 ± 0.26 0.76 ± 0.25 2.921 0.004 Bicep’s circumference (mm) 28.62 ± 2.31 29.11 ± 3.24 1.115 0.126 MAMC (mm) 21.62 ± 2.74 23.08 ± 2.72 3.548 <0.001
SA, serum albumin; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; GS, grip strength; WS, walking speed; MAMC, midarm muscle circumference.